Allan May

Allan brings over 30 years of early stage medical device investing to MCF.

Allan joined in 2020 as a venture partner to the Medtech Convergence Fund (MCF). He is co-founder of Life Science Angels.

Previous Experience
Allan is co-founder of Life Science Angels, a Bay Area early stage investment group focused on supporting innovative biotech, medical device, diagnostic and mobile health companies. Allan was also co-founder of Emergent Medical Partners, a $70M venture fund focused on early-stage medical device and diagnostic companies. Allan has been Chairman or CEO to 10 start-up medical device and diagnostic companies, and an investor in over 65 medtech, biotech, and diagnostic start-ups since 1995. In addition, Allan co-founded Nanostim, developer of the first Leadless Cardiac Pacemaker, and Hyalex Surgical, developer of synthetic cartilage for total joints.